drugset / Trial / NCT00454272

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

NCT00454272

Phase 4 Completed 197 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the efficacy and safety of Teicoplanin versus Vancomycin as part of the initial antibiotic regimen in the therapy of patients with fever and neutropenia .

Timeline

Start
2005-01
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Teicoplanin Other / unclassified
Comparator Vancomycin Other / unclassified